Medical Imaging AI Company Seeking Equity Investment for IP Acquisition

This listing represents an investment opportunity in a medical imaging company focused on breast cancer detection. The company utilizes advanced Artificial Intelligence (AI) and Ultrasound technology. Significant investment (over US$5 Million since 2013) has already gone into developing this technology. The core intellectual property (IP) and patents are available for acquisition. The current CEO is seeking US$550,000 in equity funding to acquire this IP and patents and establish a commercial enterprise. The pre-money valuation for this venture is US$3 Million. The company is based in Switzerland and operates within the Medical / Pharmaceutical / Biotech sector.